Not applicableWithdrawnNCT02526719What this trial is testingNipple Delay Prior to Nipple Sparing Mastectomy: A Pilot RCTWho this might be right forBreast Cancer University Health Network, Toronto
Not applicableActive Not RecruitingNCT02760849What this trial is testingSurgery in Preventing Ovarian Cancer in Patients With Genetic MutationsWho this might be right forDeleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more M.D. Anderson Cancer Center 374
Not applicableUnknownNCT04983628What this trial is testingMolecular Profiling in Prostate CancerWho this might be right forProstate Cancer MetastaticProstate Cancer RecurrentGermline BRCA1 Gene Mutation+2 more Hellenic Cooperative Oncology Group 250
Testing effectiveness (Phase 2)Looking for participantsNCT05485766What this trial is testingNovel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast CancerWho this might be right forTriple Negative Breast NeoplasmsTriple Negative Breast CancerBreast Neoplasms+5 more Okayama University 23
Not applicableActive Not RecruitingNCT02194387What this trial is testingEnergy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family MembersWho this might be right forBody Mass Index 25 or GreaterBRCA1 Gene MutationBRCA2 Gene Mutation+8 more M.D. Anderson Cancer Center 337
Testing effectiveness (Phase 2)Study completedNCT02282345What this trial is testingTalazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast CancerWho this might be right forBreast AdenocarcinomaDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+2 more M.D. Anderson Cancer Center 36
Early research (Phase 1)Study completedNCT01339650What this trial is testingStudy of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian TubePrimary Peritoneal CancerSolid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian AbbVie (prior sponsor, Abbott) 93
Testing effectiveness (Phase 2)Study completedNCT00628251What this trial is testingDose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian CancerWho this might be right forOvarian Neoplasms AstraZeneca 97
Not applicableStudy completedNCT04823871What this trial is testingEarly Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex SequencingWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Paul Speiser, Prof.MD, 406
Not applicableStudy completedNCT01346761What this trial is testingRisk Education and Assessment for Cancer HeredityWho this might be right forBreast CancerOvarian CancerGenetic Predisposition University of Utah 1,012
Testing effectiveness (Phase 2)Looking for participantsNCT04090567What this trial is testingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 60
Not applicableStudy completedNCT02197000What this trial is testingA Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) CarriersWho this might be right forBRCA1 Gene MutationBRCA2 Gene Mutation Rabin Medical Center 23
Not applicableStudy completedNCT01975363What this trial is testingPilot Study of Curcumin for Women With Obesity and High Risk for Breast CancerWho this might be right forAtypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene Mutation+2 more Ohio State University Comprehensive Cancer Center 29
Not applicableLooking for participantsNCT07292246What this trial is testingA Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)Who this might be right forBreast CancerBRCA 1 Gene MutationBRCA 2 Gene Mutation+5 more Vasileios Kalles 15
Testing effectiveness (Phase 2)Study completedNCT00494442What this trial is testingStudy to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerWho this might be right forOvarian Neoplasm AstraZeneca 58
Testing effectiveness (Phase 2)Study completedNCT02953457What this trial is testingOlaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 MutationWho this might be right forBRCA1 Gene MutationBRCA2 Gene MutationOvarian Serous Adenocarcinoma+3 more Roswell Park Cancer Institute 40
Early research (Phase 1)Ended earlyNCT04182516What this trial is testingStudy of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid TumorsWho this might be right forAdvanced/Metastatic Solid Tumors Nerviano Medical Sciences 52
Not applicableEnded earlyNCT04668521What this trial is testingMultifactorial Risk Assessment for Breast & Ovarian Cancer Risk DetectionWho this might be right forAdnexal MassGermline BRCA1 Gene MutationGermline BRCA2 Gene Mutation+1 more Aspira Women's Health 215
Testing effectiveness (Phase 2)UnknownNCT04556292What this trial is testingA Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer PatientsWho this might be right forBreast Cancer MetastaticBRCA 1 Gene MutationBRCA 2 Gene Mutation Jiangxi Qingfeng Pharmaceutical Co. Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT03377556What this trial is testingLung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung CancerWho this might be right forATM Gene MutationATR Gene MutationBARD1 Gene Mutation+18 more SWOG Cancer Research Network 51